252 related articles for article (PubMed ID: 11447289)
1. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways.
Hadari YR; Gotoh N; Kouhara H; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8578-83. PubMed ID: 11447289
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.
Ong SH; Hadari YR; Gotoh N; Guy GR; Schlessinger J; Lax I
Proc Natl Acad Sci U S A; 2001 May; 98(11):6074-9. PubMed ID: 11353842
[TBL] [Abstract][Full Text] [Related]
3. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
Wu Y; Chen Z; Ullrich A
Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
[TBL] [Abstract][Full Text] [Related]
4. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
Klint P; Kanda S; Kloog Y; Claesson-Welsh L
Oncogene; 1999 Jun; 18(22):3354-64. PubMed ID: 10362356
[TBL] [Abstract][Full Text] [Related]
6. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
[TBL] [Abstract][Full Text] [Related]
7. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway.
Lamothe B; Yamada M; Schaeper U; Birchmeier W; Lax I; Schlessinger J
Mol Cell Biol; 2004 Jul; 24(13):5657-66. PubMed ID: 15199124
[TBL] [Abstract][Full Text] [Related]
8. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
9. Docking protein SNT1 is a critical mediator of fibroblast growth factor signaling during Xenopus embryonic development.
Akagi K; Kyun Park E; Mood K; Daar IO
Dev Dyn; 2002 Mar; 223(2):216-28. PubMed ID: 11836786
[TBL] [Abstract][Full Text] [Related]
10. The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors.
Lax I; Wong A; Lamothe B; Lee A; Frost A; Hawes J; Schlessinger J
Mol Cell; 2002 Oct; 10(4):709-19. PubMed ID: 12419216
[TBL] [Abstract][Full Text] [Related]
11. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
Hanafusa H; Torii S; Yasunaga T; Nishida E
Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
13. FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
Li X; Brunton VG; Burgar HR; Wheldon LM; Heath JK
J Cell Sci; 2004 Dec; 117(Pt 25):6007-17. PubMed ID: 15564375
[TBL] [Abstract][Full Text] [Related]
14. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl.
Wong A; Lamothe B; Lee A; Schlessinger J; Lax I
Proc Natl Acad Sci U S A; 2002 May; 99(10):6684-9. PubMed ID: 11997436
[TBL] [Abstract][Full Text] [Related]
15. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.
Landgren E; Klint P; Yokote K; Claesson-Welsh L
Oncogene; 1998 Jul; 17(3):283-91. PubMed ID: 9690510
[TBL] [Abstract][Full Text] [Related]
17. FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway.
Zhou W; Feng X; Wu Y; Benge J; Zhang Z; Chen Z
Cell Res; 2009 Oct; 19(10):1165-77. PubMed ID: 19652666
[TBL] [Abstract][Full Text] [Related]
18. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.
Kovalenko D; Yang X; Nadeau RJ; Harkins LK; Friesel R
J Biol Chem; 2003 Apr; 278(16):14087-91. PubMed ID: 12604616
[TBL] [Abstract][Full Text] [Related]
19. Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain.
Burgar HR; Burns HD; Elsden JL; Lalioti MD; Heath JK
J Biol Chem; 2002 Feb; 277(6):4018-23. PubMed ID: 11729184
[TBL] [Abstract][Full Text] [Related]
20. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway.
Kouhara H; Hadari YR; Spivak-Kroizman T; Schilling J; Bar-Sagi D; Lax I; Schlessinger J
Cell; 1997 May; 89(5):693-702. PubMed ID: 9182757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
